Jun, 2010
News / Press Releases
Astellas Announces Oral Presentation of SGLT2 Inhibitor Detailing Safety and Efficacy in Patients with Type 2 Diabetes at the American Diabetes Association Meeting(pdf40 KB)
Read More
News / Press Releases
Allotment of Stock Acquisition Rights (pdf76 KB)
Read More
News / Press Releases
Application for Mirabegron (YM178), a Treatment for OAB, in Japan (pdf42 KB)
Read More
News / Press Releases
Astellas' Brazilian Affiliate Initiates Business Operations(pdf38 KB)
Read More
Apr, 2024
Apr, 2024
Feb, 2024
Nov, 2023
Mar, 2024
Feb, 2024
Oct, 2023
Sep, 2023
Nothing Found
Unfortunately, we weren't able to find a match for your search query. Please try again.
Nothing Found
Unfortunately, we weren't able to find a match.